Apontis Pharma AG (APPH) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.061x

Based on the latest financial reports, Apontis Pharma AG (APPH) has a cash flow conversion efficiency ratio of -0.061x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.94 Million ≈ $-2.27 Million USD) by net assets (€31.62 Million ≈ $36.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Apontis Pharma AG - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Apontis Pharma AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Apontis Pharma AG balance sheet liabilities for a breakdown of total debt and financial obligations.

Apontis Pharma AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apontis Pharma AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lakeshore Acquisition III Corp. Ordinary Shares NASDAQ:LCCC	-0.001x
Aniplus Inc KQ:310200	0.106x
Rani Therapeutics Holdings Inc NASDAQ:RANI	0.423x
Galleon Gold Corp V:GGO	-0.019x
Summit State Bank NASDAQ:SSBI	0.071x
Manoj Vaibhav Gems 'N' Jewellers Limited NSE:MVGJL	0.128x
Krystal Integrated Services Ltd NSE:KRYSTAL	-0.028x
Oneview Healthcare Plc AU:ONE	-1.027x

Annual Cash Flow Conversion Efficiency for Apontis Pharma AG (2019–2024)

The table below shows the annual cash flow conversion efficiency of Apontis Pharma AG from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Apontis Pharma AG (APPH) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€31.02 Million ≈ $36.26 Million	€-2.90 Million ≈ $-3.39 Million	-0.094x	+77.54%
2023-12-31	€30.26 Million ≈ $35.38 Million	€-12.60 Million ≈ $-14.73 Million	-0.416x	-257.05%
2022-12-31	€41.57 Million ≈ $48.60 Million	€11.02 Million ≈ $12.88 Million	0.265x	+214.37%
2021-12-31	€40.71 Million ≈ $47.60 Million	€3.43 Million ≈ $4.01 Million	0.084x	-79.90%
2020-12-31	€3.46 Million ≈ $4.04 Million	€1.45 Million ≈ $1.70 Million	0.420x	+917.97%
2019-12-31	€4.64 Million ≈ $5.43 Million	€-238.07K ≈ $-278.33K	-0.051x	--

About Apontis Pharma AG

XETRA:APPH Germany Drug Manufacturers - Specialty & Generic

Market Cap

$107.13 Million

€91.63 Million EUR

Market Cap Rank

#19522 Global

#1792 in Germany

Share Price

€11.00

Change (1 day)

+0.00%

52-Week Range

€10.75 - €12.10

All Time High

€26.90